About Università di Modena e Reggio Emilia
L'Università di Modena e Reggio Emilia è un'università statale italiana, fra le più antiche d'Europa, le cui origini come Studium a Modena risalgono al 1175 e, a Reggio, al 1188. Dopo diversi secoli, fu rifondata nel 1682.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
National Institute of Allergy and Infectious Diseases (NIAID)
2
Fondazione Italiana Linfomi ONLUS
1
Northwestern University
1
Policlinico Casilino ASL RMB
1
Reata Pharmaceuticals, Inc.
1
Rigshospitalet, Denmark
1
Skin Analytics Limited
1
University Health Network, Toronto
1
Clinical Trials at Università di Modena e Reggio Emilia
During the past decade, Università di Modena e Reggio Emilia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
Completed
240
Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study
2005-06-01
2008-06-01
Completed
50
Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters
2009-04-01
2019-04-01
Unknown status
100
Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)
2010-06-25
2016-09-26
Completed
198
RadIal Versus Femoral InvEstigation in ST Elevation Acute Coronary Syndrome
2009-01-01
2012-07-01
Unknown status
1,001
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
2012-06-06
2021-02-01
Completed
752
An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
2013-07-17
2023-12-31
Active, not recruiting
481
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Università di Modena e Reggio Emilia" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials
sponsored, "Fondazione Italiana Linfomi ONLUS" with 1 trials sponsored, "Northwestern University" with 1 trials sponsored and "Policlinico Casilino ASL RMB"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Università di Modena e Reggio Emilia"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "CIHR Canadian HIV Trials Network" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "San Raffaele University Hospital, Italy" with 1 trials as a collaborator and "University College, London" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Università di Modena e Reggio Emilia
According to Clinical.Site data, the most researched conditions in "Università di Modena e Reggio Emilia" are
"HIV" (2 trials), "HIV Infections" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "ADPKD" (1 trials) and "AIDS" (1 trials). Many other conditions were trialed in "Università di Modena e Reggio Emilia" in a lesser frequency.
Clinical Trials Intervention Types at Università di Modena e Reggio Emilia
Most popular intervention types in "Università di Modena e Reggio Emilia" are "Drug" (8 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nintedanib" (2 trials), "Atazanavir" (1 trials), "BIBF 1120" (1 trials), "Bardoxolone methyl oral capsule" (1 trials) and "Deep Ensemble for the Recognition of Malignancy (DERM)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Università di Modena e Reggio Emilia
The vast majority of trials in "Università di Modena e Reggio Emilia" are
12 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Università di Modena e Reggio Emilia
Currently, there are NaN active trials in "Università di Modena e Reggio Emilia".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 8 completed trials in Università di Modena e Reggio Emilia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Università di Modena e Reggio Emilia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".